Publications en collaboration avec des chercheurs de Instituto Valenciano de Oncologia (15)

2024

  1. Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients

    Journal of the American Academy of Dermatology, Vol. 90, Núm. 1, pp. 66-73

2023

  1. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

  2. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study

    Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693

2020

  1. Breakthrough cancer pain: review and calls to action to improve its management

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1216-1226

2019

  1. Clinical impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer treated with first-line chemotherapy plus anti–epidermal growth factor receptor therapy

    JCO Precision Oncology, Vol. 3

  2. Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy before Standard Chemoradiotherapy and Surgery in Patients with High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial

    JAMA Oncology, Vol. 5, Núm. 11, pp. 1566-1573

2018

  1. Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea

    European Respiratory Journal, Vol. 51, Núm. 3

  2. Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

    Neoplasia (United States), Vol. 20, Núm. 7, pp. 678-686

  3. Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients

    Chest, Vol. 154, Núm. 6, pp. 1348-1358

2017

  1. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: Long-term results from the GEMCAD 0801 trial

    Annals of Oncology, Vol. 28, Núm. 2, pp. 344-353

  2. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

    British Journal of Cancer, Vol. 117, Núm. 12, pp. 1777-1786

2016

  1. Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series

    Journal of Dermatology, Vol. 43, Núm. 5, pp. 553-556

2014

  1. Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: The GEMCAD 0801 phase II multicenter trial

    Oncologist, Vol. 19, Núm. 10, pp. 1042-1043

2013

  1. Registro nacional de melanoma cutáneo. Características del tumor en el momento del diagnóstico: 15 años de experiencia

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 9, pp. 789-799

2010

  1. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cáncer de Recto 3 study

    Journal of Clinical Oncology, Vol. 28, Núm. 5, pp. 859-865